150 related articles for article (PubMed ID: 3123643)
21. Effects of feeding and fasting on the insulin secretory response to glucose and sulfonylureas in intact rats and isolated perfused rat pancreas.
Bosboom RS; Zweens J; Bouman PR
Diabetologia; 1973 Aug; 9(4):243-50. PubMed ID: 4203349
[No Abstract] [Full Text] [Related]
22. Chronic exposure to tolbutamide and glibenclamide impairs insulin secretion but not transcription of K(ATP) channel components.
Ball AJ; McCluskey JT; Flatt PR; McClenaghan NH
Pharmacol Res; 2004 Jul; 50(1):41-6. PubMed ID: 15082027
[TBL] [Abstract][Full Text] [Related]
23. Effects of salicylate, tolbutamide, and prostaglandin E2 on insulin responses to glucose in noninsulin-dependent diabetes mellitus.
Giugliano D; Ceriello A; Saccomanno F; Quatraro A; Paolisso G; D'Onofrio F
J Clin Endocrinol Metab; 1985 Jul; 61(1):160-6. PubMed ID: 3923028
[TBL] [Abstract][Full Text] [Related]
24. [Extrapancreatic effects of sulfonylurea compounds. IV. Increase of the effect of insulin due to tolbutamide, glibornuride, and glibenclamide in vitro].
Beyer J; Gather W; Schöffling K
Arzneimittelforschung; 1972 Dec; 22():Suppl 12A:2179. PubMed ID: 4198966
[No Abstract] [Full Text] [Related]
25. [The influence of various sulphonylurea derivatives on the oral glucose-tolerance tests in healthy subjects and obese and maturity-onset diabetics (author's transl)].
Haupt E; Beyer J; Schöffling K
Dtsch Med Wochenschr; 1974 Mar; 99(9):385-8. PubMed ID: 4208186
[No Abstract] [Full Text] [Related]
26. Significance of acid amyloglucosidase in sulphonylurea-induced insulin release.
Lundquist I
Diabetologia; 1974 Dec; 10(6):717-24. PubMed ID: 4374400
[No Abstract] [Full Text] [Related]
27. [Studies on new sulfonylurea derivatives and their metabolites in isolated Langerhans's islets of the rat pancreas (author's transl].
Krause U; Puchinger H; Wacker A
Arzneimittelforschung; 1975 Aug; 25(8):1231-3. PubMed ID: 810148
[TBL] [Abstract][Full Text] [Related]
28. The effect of glimepiride on pancreatic beta-cell function under hyperglycaemic clamp and hyperinsulinaemic, euglycaemic clamp conditions in non-insulin-dependent diabetes mellitus.
Clark HE; Matthews DR
Horm Metab Res; 1996 Sep; 28(9):445-50. PubMed ID: 8911981
[TBL] [Abstract][Full Text] [Related]
29. Special pharmacology of the new sulfonylurea glimepiride.
Geisen K
Arzneimittelforschung; 1988 Aug; 38(8):1120-30. PubMed ID: 2904269
[TBL] [Abstract][Full Text] [Related]
30. Glibenclamide, a new sulphonylurea: whither oral hypoglycaemic agents?
Marble A
Drugs; 1971; 1(2):109-15. PubMed ID: 4999930
[No Abstract] [Full Text] [Related]
31. The pharmacology of a new hypoglycaemic agent N-[4-(2-(2,3-dihydrobenzo(b)furan-m-carboxamido)-ethyl)-benzenesulphonyl]-N'-cyclohexylurea (NOVO CS 476). I. Pharmacological studies on the hypoglycaemic effect.
Jorgensen KD
Acta Pharmacol Toxicol (Copenh); 1977 Feb; 40(2):216-26. PubMed ID: 402791
[TBL] [Abstract][Full Text] [Related]
32. [Studies on the effect of various sulfonylureas during adrenergic blockade of the insulin secretion in man].
Haslbeck M; Brauch K; Hepp KD; Mehnert H
Verh Dtsch Ges Inn Med; 1971; 77():543-6. PubMed ID: 5005529
[No Abstract] [Full Text] [Related]
33. [Insulin secretion after oral and intravenous administration of various 1st and 2d generation sulfonylurea derivatives in equipotential dosage].
Haupt E; Köberich W; Rosak C; Cordes U; Beyer J; Schöffling K
Verh Dtsch Ges Inn Med; 1972; 78():1272-5. PubMed ID: 4198780
[No Abstract] [Full Text] [Related]
34. Interacting effects of sulfonylureas and glucose on cyclic AMP metabolism and insulin release in pancreatic islets of the rat.
Grill V; Cerasi E
J Clin Invest; 1978 May; 61(5):1346-54. PubMed ID: 207736
[TBL] [Abstract][Full Text] [Related]
35. Sulfonylurea enhances insulin-induced acetyl coenzyme A carboxylase activity in rat adipocytes.
Matsuda M; Kaku K; Aoki M; Inoue H; Kaneko T
Horm Metab Res; 1991 May; 23(5):209-12. PubMed ID: 1678729
[TBL] [Abstract][Full Text] [Related]
36. Phosphoinositide hydrolysis and insulin secretion in response to glucose stimulation are impaired in isolated rat islets by prolonged exposure to the sulfonylurea tolbutamide.
Zawalich WS
Endocrinology; 1989 Jul; 125(1):281-6. PubMed ID: 2544404
[TBL] [Abstract][Full Text] [Related]
37. [Effect of gliquidone and glibenclamide following oral administration].
Ziler T; Waldthaler A; Ermler R; Bottermann P
MMW Munch Med Wochenschr; 1975 Sep; 117(36):1423-4. PubMed ID: 809687
[TBL] [Abstract][Full Text] [Related]
38. [The insulin-secreting and proliferative activity of established islet cells in the presence of sulfonylurea].
Balabolkin MI; Timofeev AV; Danilova TI; Zhuleva LIu; Ol'shanskaia AA
Biull Eksp Biol Med; 1992 Oct; 114(10):406-8. PubMed ID: 1288706
[TBL] [Abstract][Full Text] [Related]
39. Biochemical and morphological events associated with the development of fetal rat pancreas "in vivo" and "in vitro": effect of glucagon and of other agents.
Lambert AE; Orci L; Kanazawa Y; Jeanrenaud B; Renold AE
Acta Isot (Padova); 1970; 10(3):191-204. PubMed ID: 4334397
[No Abstract] [Full Text] [Related]
40. Different effects of prostaglandin E1, E2 and D2 on pancreatic somatostatin release.
Nishi S; Seino Y; Seino S; Tsuda K; Takemura J; Shimizu T; Hayashi O; Imura H
Horm Metab Res; 1984 Dec; 16 Suppl 1():114-8. PubMed ID: 6152434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
